Loading

VerImmune Inc

June 03, 2024
Company Presentation
Oncology
Company Presentation Theater 1
VerImmune is developing an innovative and programmable Virus-inspired Particle (ViP) platform that can be used as a delivery system to target and treat numerous diseases. The lead program is an innovative first-in-class oncology therapeutic that redirects pre-existing viral or childhood vaccine immunity to target cancers.
Speakers
Joshua Wang, PhD
Founder & CEO
VerImmune Inc
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS